With the big ASH meeting ongoing, we have more biotech stocks to watch for big news in the week ahead. I'm feeling better about risk-on biotech stocks with the Federal
Biotech stock Immune Design (IMDZ) just released the big news we have been waiting for over this weekend's news cycle. Immune Design just announced long-term follow up results from a
International Business Machines Corporation (IBM) stock looks like a good setup after the stock has done a 50% Fibonacci retracement.
On Tuesday, October 17, 2017, IBM reported EPS of $3.30 versus
The top large cap growth ETF to trade right now is the iShares Core S&P US Growth ETF IUSG. This ETF tracks the S&P 900 Growth Index which measures growing
The stock of PRA Health Sciences looks like a compelling entry on a momentum squeeze after the company announced a partnership with Jumo.
PRA Health recently announced a partnership with Jumo,
The stock chart of Cerner Corporation shows a momentum squeeze candidate on excellent sales growth and new business from the Carolinas HealthCare System (CHS).
Cerner announced on June 21, 2017, that
May 18, 2017: S&P raises Centene's rating one notch to BB+ from BB with an outlook rating of stable. "The rating upgrade on Centene reflects the company's continued successful execution
March 4, 2017: Sell Exact Sciences for a 55% win in 37 days. Congratulations if you were able to make money on the trade and always remember to sell your
The Department of Veterans Affairs is on the cutting edge of IoT medical devices. This is great news for medical device stocks and more specifically telehealth companies like Koninklijke Philips